je.st
news
Tag: pollen
Longer pollen seasons nothing to sneeze at
2013-07-28 10:29:28| Biotech - Topix.net
"I feel like this is our new reality," McIntyre said recently of the allergies that have begun to plague her.
Tags: longer
seasons
pollen
sneeze
Hurricane Sandy and Climate Change Drive Up the Pollen Count
2013-06-05 10:54:00| Climate Ark Climate Change & Global Warming Newsfeed
Daily Beast: FIRST THE heat. Then the storms. Now the ... pollen? Massive quantities of pollen are floating through the air, causing people to sniff, sneeze, and itch. And it turns out a changing climate could be to blame. In the Northeast, tree pollen is at the highest level in the 25 years that Leonard Bielory, an allergy and immunology expert at Rutgers Universitys Center for Environmental Prediction, has been tracking it. He says its a continuation of a trend hes been seeing for years, and he expects...
Tags: change
drive
count
climate
From 'Potent' Pollen to Double Whammy Allergy Seasons
2013-05-17 12:17:00| Climate Ark Climate Change & Global Warming Newsfeed
ABC: Climate changes and rising carbon dioxide levels don't just affect the environment. Experts say they also affect your nose. Warmer temperatures and higher carbon dioxide levels mean certain plants will thrive, and those are the plants that tend to make us sneeze during allergy season. Allergies may seem like a minor nuisance, but according to the CDC there are an estimated 50 million Americans living with allergies, and $18 billion is spent every year dealing with the affliction. From hay fever...
Tags: double
seasons
allergy
potent
Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet
2013-05-08 14:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Biologics License Application (BLA) for its investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration (FDA). On March 27, Merck announced that the FDA had also accepted the BLA for its investigational Timothy grass pollen (Phleum pratense) sublingual allergy immunotherapy tablet. Language: English Contact HTML: MerckMedia:Pam Eisele, 908-423-5042Robert Consalvo, 908-423-6595orInvestor:Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: application
license
acceptance
announces
Merck Announces FDA Acceptance of Biologics License Application for Investigational Grass Pollen Allergy Immunotherapy Tablet
2013-03-27 13:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Biologics License Application (BLA) for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet (AIT) has been accepted for review by the U.S. Food and Drug Administration (FDA). In March, the company also submitted a BLA to the FDA for its investigational ragweed pollen (Ambrosia artemisiifolia) AIT. Language: English Contact HTML: MerckMedia:Pam Eisele, (908) 423-5042Tracy Ogden, (267) 305-2301orInvestors:Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: application
license
acceptance
grass